Publicaciones en colaboración con investigadoras/es de David Geffen School of Medicine at UCLA (11)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

    Nature Communications, Vol. 11, Núm. 1

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

    Movement Disorders, Vol. 31, Núm. 5, pp. 742-747

2015

  1. Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy

    Journal of Neuropathology and Experimental Neurology, Vol. 74, Núm. 4, pp. 370-379

2014

  1. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

    Movement Disorders, Vol. 29, Núm. 4, pp. 470-478

2013

  1. The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    American Journal of Psychiatry, Vol. 170, Núm. 11, pp. 1249-1262

2012

  1. C3KO mouse expression analysis: Downregulation of the muscular dystrophy Ky protein and alterations in muscle aging

    Neurogenetics, Vol. 13, Núm. 4, pp. 347-357

  2. Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3

    Human Molecular Genetics, Vol. 21, Núm. 14, pp. 3193-3204

2010

  1. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Nature Genetics, Vol. 42, Núm. 3, pp. 234-239

  2. LIM-homeobox gene Lhx5 is required for normal development of Cajal-Retzius cells

    Journal of Neuroscience, Vol. 30, Núm. 31, pp. 10551-10562